Open-House Biologics Discount Contracts 2026-06 - Teriparatide

Auto-translated from Englisch

Original title: Open-House-Biologika-Rabattverträge 2026-06 - Teriparatid

Techniker Krankenkasse

Published: Mar 16, 2026

Updated: May 10, 2026

Source: TED - Tenders Electronic Daily (EU)

Summary

Translated

This tender aims to establish drug discount contracts according to § 130a Abs. 8 SGB V for the active substance Teriparatide. The procurement will be conducted through an 'Open-House' procedure, allowing multiple manufacturers or suppliers to participate and offer their products under negotiated discount terms. The focus is on securing cost-effective supply of Teriparatide, a medication likely used for specific medical conditions, through competitive bidding and subsequent contractual agreements. The 'Open-House' model facilitates ongoing participation and potential renegotiation, ensuring continued access to discounted pharmaceuticals for the contracting entity.

Description

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Teriparatid im Rahmen eines Open-House-Verfahrens.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before April 29, 2028.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.